Research Alliance Corporation III (RACC)
Research Alliance Corporation III will go public soon, but the exact IPO date is still unknown.
IPO Price
$10.00
Shares Offered
5,000,000
Deal Size
$50.00M
Company Description
Research Alliance Corporation III is a newly organized blank check company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.
We intend to focus on industries that complement our management team’s background, and to capitalize on the ability of our management team to identify and acquire a business, focusing on the healthcare or healthcare-related industries.
In particular, we are targeting companies in the drug development and commercialization, diagnostic and healthcare technology and service sectors where our management has extensive investment experience.
Research Alliance Corporation III
| Country | United States |
| Founded | 2026 |
| Industry | Shell Companies |
| Sector | Financials |
| CEO | Matthew Hammond |
Contact Details
Address: 600 Fifth Avenue, 23rd Floor New York, NY 10020 United States | |
| Phone | (617) 778 2500 |
Stock Details
| Ticker Symbol | RACC |
| Exchange | NASDAQ |
| Reporting Currency | USD |
| IPO Price | $10.00 |
| CIK Code | 0002118032 |
| Employer ID | 98-1918931 |
Key Executives
| Name | Position |
|---|---|
| Matthew Hammond, Ph.D. | Chief Executive Officer and Director |
| Henry Stusnick | Chief Business Officer and Chief Operating Officer |
| Fran Adams | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 23, 2026 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Mar 24, 2026 | S-1 | General form for registration of securities under the Securities Act of 1933 |